THERAVANCE BIOPHARMA, INC. (TBPH) Capital expenditures 2012–2016
THERAVANCE BIOPHARMA, INC. (TBPH) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$2.1MFY2016 · since FY2012: $2.6M → $2.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2016 | $2.1M | -19.3% |
| FY2015 | $2.6M | -14.8% |
| FY2014 | $3.1M | +13.6% |
| FY2013 | $2.7M | +5.6% |
| FY2012 | $2.6M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice